Nerai Bioscience AG

Nerai is a pioneering biotechnology company based in Switzerland, focused on revolutionizing genetic medicine. By harnessing the most advanced CRISPR and protein engineering technologies, Nerai develops tailor-made, highly precise, and personalized genome editors at scale, addressing previously unreachable diseases and rewriting the rules of therapeutic genome editing.

Our mission is to bring curative, one-time genetic therapies to patients suffering from rare inherited diseases, with initial programs targeting the liver and retina. Founded by a multidisciplinary team of scientists and entrepreneurs, Nerai is committed to translating world-class science into transformative patient impact. By combining innovation with strategic partnerships in the biopharmaceutical industry, we strive to become a global leader in genome editing and redefine the future of the healthcare industry.